Incidence of Ductal Carcinoma In Situ in the United States, 2000–2014
Abstract
In absence of definitive molecular risk markers, clinical management of patients diagnosed with ductal carcinoma in situ (DCIS) remains largely guided by patient and tumor characteristics. In this study, we analyzed recent trends in DCIS incidence and compared them against trends in mammography use.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 01, 2019
- Source ID
- 10.1158/1055-9965.epi-18-1262
Entities
People
- E. Shelley Hwang
- Laura H. Hendrix
- Marc D. Ryser
- Mathias Worni
- Terry Hyslop
- Yiling Liu
Organizations
- Duke University
- Duke University Hospital
- National Institutes of Health
- National Science Foundation
- Patient-Centered Outcomes Research Institute
- United States Department of Defense
- University of Bern